Gland Pharma said that the United States Food and Drug Administration (US FDA) has conducted an un-announced inspection of the company’s Pashamylaram Facility at Hyderabad for good manufacturing practices (GMP).
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
